SEC Hits Biotech Investor With Market Manipulation Suit – site.law360.com

May 10, 2012 Posted By: Leave a comment
Law360, New York (May 10, 2012, 7:00 PM ET) -- Biotechnology financier David Blech, who pled guilty Wednesday to securities fraud for manipulating the stock prices of two biotech companies, will now have to face off with the U.S. Securities and Exchange ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>